Healthcare service provider Astrana Health has recently reaffirmed its financial targets for the fiscal year 2026.

The company expects total annual revenue to reach the range of $3.8 billion to $4.1 billion, demonstrating robust growth momentum. In terms of profitability, Astrana Health expects adjusted EBITDA to be between $250 million and $280 million, fully reflecting the ongoing optimization of the company’s operational efficiency. More notably, the company’s forecast for free cash flow remains at the level of $105 million to $1.325 billion. Strong cash flow generation will provide solid support for Astrana Health’s future development strategies. The reaffirmed earnings guidance is entirely consistent with the company’s previously announced expectations, highlighting management’s full confidence in achieving these financial goals.